瘤中RNA结合蛋白和非编码RNA之间的交叉:分子机制和临床意义
Shiwen Cui1,2,3, Qiu Peng1,2, Qianfeng Ma1,2
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
International journal of biological sciences
|May 19, 2025
概括
RNA结合蛋白和非编码RNA在瘤进展中至关重要. 本综述探讨了它们的复杂相互作用,揭示了对瘤发生和潜在治疗点的见解.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 遗传学 遗传学 是一个
背景情况:
- RNA结合蛋白 (RBPs) 和非编码RNA (ncRNAs) 是基因表达的关键调节者.
- RBPs和ncRNA都在瘤发育和进展中发挥着关键作用.
- 在癌症中,RBP和ncRNA的复杂网络和协作功能仍然不完全理解.
研究的目的:
- 提供RBPs及其相关ncRNAs在瘤生物学中的作用的全面审查.
- 探索RBPs和ncRNAs影响瘤进展的机制.
- 在各种癌症特征中阐明RBPs和ncRNA之间的交互网络.
主要方法:
- 文献综述和现有研究结果的综合.
- 在与癌症相关的过程中分析特定RBP的功能 (例如,替代拼接,m6A修饰).
- 检查各种ncRNAs (miRNAs, lncRNAs, circRNAs) 在瘤发生中的作用.
主要成果:
- RBPs参与了关键的细胞过程,如瘤中的替代拼接,m6A修饰和相分离.
- ncRNAs,包括microRNAs,长非编码RNAs和circRNAs,显著影响瘤的进展.
- RBPs和ncRNA之间的相互作用影响代谢重编程,免疫力,耐药性,转移和铁亡.
结论:
- 了解RBPs和ncRNAs的协作功能对于理解瘤发生至关重要.
- RBP-ncRNA网络为开发新型癌症治疗策略提供了有前途的途径.
- 对这些相互作用的进一步研究将进一步深入了解癌症机制和治疗可能性.
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Types of RNA
5.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.5K
RNA Splicing
55.8K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Regulation of Expression at Multiple Steps
857
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
857
RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K


